Showing results (71-80 of 262) with videos related to
Sort By:
Pageof 27
Cancers|June 10, 2023
Radiotherapy in Combination with Systemic Therapy for Multiple Myeloma-A Critical Toxicity Evaluation in the Modern Treatment EraMichael Oertel, Tom Schlusemann, Evgenii Shumilov, et al.Frontiers in Oncology|August 5, 2022
The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple MyelomaSarah Sandmann, Katharina Karsch, Peter Bartel, et al.Proceedings of the National Academy of Sciences of the United States of America|December 22, 2010
Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cellsBernhard Kloo, Daniel Nagel, Matthias Pfeifer, et al.Cancers|November 27, 2021
The Burden of Survivorship on Hematological Patients-Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell TransplantationMichael Oertel, Jonas Martel, Jan-Henrik Mikesch, et al.Transplantation and Cellular Therapy|April 28, 2021
Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive TherapyWolfgang Roll, Georg Evers, Rebecca Strotmann, et al.Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditionsFlorian Scholz, Michael Grau, Lutz Menzel, et al.Proceedings of the National Academy of Sciences of the United States of America|December 16, 2015
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activationNathalie Knies, Begüm Alankus, Andre Weilemann, et al.Journal of Extracellular Vesicles|March 7, 2024
PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancerNadja Schöne, Marcel Kemper, Kerstin Menck, et al.Annals of Hematology|February 7, 2023
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysisDavid Kuron, Alexander Pohlmann, Linus Angenendt, et al.Oncotarget|September 22, 2021
Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibitionMarcel Kemper, Georg Evers, Arik Bernard Schulze, et al.Pageof 27